Search

Charito S Buensuceso

from Hopkinton, MA
Age ~56
Get Report
Also known as:
Chrito S Buensuceso, Charito S Kuhn
Phone and address:
8 Wayside Dr, Hopkinton, MA 01748
Related to:
Delfin R BuensucesoElenita S Buensuceso, 81Jhon S Buensuceso, 47Faye O Buensuceso, 54Alain S Buensuceso, 57Klaus Kuhn, 64
Connected to:
Irene K Buensuceso, 36Mario D Buensuceso, 74Mark R Buensuceso, 32Rodolfo P Buensuceso, 55Andre R Buentello, 55Elisa M Buentello, 45Jesse Buentello, 39Joann Buentello, 54Leo Buentello, 51Lori E Buentemeier, 65

Charito Buensuceso Phones & Addresses

  • 8 Wayside Dr, Hopkinton, MA 01748
  • Raritan, NJ
  • 11 Petunia Dr, North Brunswick, NJ 08902 (732) 297-1876
  • Carlsbad, CA
  • San Diego, CA
  • Somerset, NJ

Publications

Us Patents

Tissue Engineering Devices For The Repair And Regeneration Of Tissue

View page
US Patent:
20060153815, Jul 13, 2006
Filed:
Dec 15, 2005
Appl. No.:
11/304091
Inventors:
Agnieszka Seyda - New Brunswick NJ, US
David Colter - Hamilton NJ, US
Charito Buensuceso - North Brunswick NJ, US
Sridevi Dhanaraj - Raritan NJ, US
Anna Gosiewska - Skillman NJ, US
Jeffrey Geesin - Doylestown PA, US
Angelo Scopelianos - Whitehouse Station NJ, US
International Classification:
A61K 35/12
C12N 5/08
A61F 2/00
US Classification:
424093700, 424423000, 435366000, 435368000, 435370000, 435372000
Abstract:
Tissue engineering devices for use in the repair or regeneration of tissue made of support scaffolds and cell sheets.

Kidney-Derived Cells And Methods Of Use In Tissue Repair And Regeneration

View page
US Patent:
20080112939, May 15, 2008
Filed:
Oct 11, 2007
Appl. No.:
11/871045
Inventors:
David C. Colter - Hamilton NJ, US
Agnieszka Seyda - Edison, CA
Charito S. Buensuceso - North Brunswick NJ, US
Anna Gosiewska - Skillman NJ, US
Assignee:
Ethicon, Inc. - Somerville NJ
International Classification:
A61K 48/00
C12N 5/08
US Classification:
424 9321, 435325, 435369
Abstract:
Isolated or purified mammalian kidney-derived cell populations from mammalian kidney tissue are provided. Methods are provided for the isolation and purification of the mammalian kidney-derived cell population. Methods for treating kidney disease are provided by administration of the isolated or purified mammalian kidney-derived cell population to a mammalian subject.

Human Umbilical Tissue-Derived Cell Compositions For The Treatment Of Incontinence

View page
US Patent:
20080311087, Dec 18, 2008
Filed:
Jun 5, 2008
Appl. No.:
12/133792
Inventors:
Anna Gosiewska - Skillman NJ, US
Agnieszka Seyda - Edison NJ, US
Charito S. Buensuceso - North Brunswick NJ, US
International Classification:
A61K 35/44
A61P 13/00
US Classification:
424 937
Abstract:
Compositions for the treatment of incontinence are disclosed. More particularly, compositions of human umbilical tissue-derived cells and a carrier are disclosed. The compositions are useful in the treatment urinary and fecal incontinence.

Tissue Fragment Compositions For The Treatment Of Incontinence

View page
US Patent:
20080311219, Dec 18, 2008
Filed:
Jun 5, 2008
Appl. No.:
12/133770
Inventors:
Anna Gosiewska - Skillman NJ, US
Agnieszka Seyda - Edison NJ, US
Charito S. Buensuceso - North Brunswick NJ, US
Sridevi Dhanaraj - Raritan NJ, US
International Classification:
A61K 35/34
A61P 13/00
US Classification:
424548
Abstract:
Compositions for the treatment of incontinence are disclosed. More particularly, compositions of viable muscle tissue fragments and a carrier are disclosed. The compositions are useful in the treatment urinary and fecal incontinence.

Encapsulated Kidney Tissue

View page
US Patent:
20090162411, Jun 25, 2009
Filed:
Dec 17, 2008
Appl. No.:
12/337413
Inventors:
Charito S. Buensuceso - North Brunswick NJ, US
David C. Colter - Hamilton NJ, US
Brian C. Kramer - Plainfield NJ, US
Agnieszka Seyda - Edison NJ, US
Assignee:
Ethicon, Incorporated - Sommerville NJ
International Classification:
A61K 9/14
A61K 35/12
A61P 13/12
US Classification:
424422, 424 937, 424 9321
Abstract:
Provided are therapeutic implants comprising renal tissue encapsulated within a polymer bead. Also disclosed are methods for treating a disease state in a subject comprising implanting within said subject a therapeutic implant comprising renal tissue encapsulated within a polymer bead. Also provided are methods for making a therapeutic implant comprising: providing renal tissue; mixing the renal tissue with a solution comprising a polymer, thereby forming a tissue-polymer suspension; extruding the tissue-polymer suspension into an bead-forming solution, thereby forming a therapeutic implant comprising beads of said polymer within which the renal tissue is encapsulated.

Decellularized Omentum Matrix And Uses Thereof

View page
US Patent:
20090163990, Jun 25, 2009
Filed:
Dec 19, 2007
Appl. No.:
11/960010
Inventors:
Chunlin Yang - Belle Mead NJ, US
Thoppil Mathew John - Easton PA, US
Anna Gosiewska - Skillman NJ, US
Charito S. Buensuceso - North Brunswick NJ, US
David C. Colter - Hamilton NJ, US
Agnieszka Seyda - Edison NJ, US
Raymond S. Shissias - Iselin NJ, US
International Classification:
A61F 2/02
A01N 1/00
A61F 2/06
US Classification:
623 115, 435 11, 623 2372
Abstract:
Methods for defatting omentum and processes for preparing an a cellular omentum i.e., devitalized or decellularized omentum, comprising extracellular matrix for implantation into a mammalian system. Also constructs for medical applications comprising decellularized omentum.

Mammary Artery Derived Cells And Methods Of Use In Tissue Repair And Regeneration

View page
US Patent:
20110076769, Mar 31, 2011
Filed:
Sep 20, 2010
Appl. No.:
12/885855
Inventors:
David C. Colter - Hamilton NJ, US
Charito Buensuceso - North Brunswick NJ, US
Christian C. Kazanecki - Martins Creek PA, US
Anna Gosiewska - Skillman NJ, US
Assignee:
Advanced Technologies and Regenerative Medicine, LLC - Raynham MA
International Classification:
C12N 5/071
US Classification:
435381, 435325
Abstract:
An isolated mammalian internal mammary artery-derived cell is disclosed. Furthermore, methods of isolating the mammalian internal mammary artery-derived cell are disclosed. The cell is useful in tissue engineering technologies, specifically in vascular tissue engineering.

Fibrin Based Scaffold, Preparation And Use Thereof

View page
US Patent:
20120039855, Feb 16, 2012
Filed:
Aug 10, 2011
Appl. No.:
13/206715
Inventors:
Roee Atlas - Givatayim, IL
Israel Nur - Moshav Timmorim, IL
Roberto Meidler - Rehovot, IL
Liliana Bar - Rehovot, IL
Charito Buensuceso - North Brunswick NJ, US
Anthony J. Kihm - Princeton NJ, US
Sridevi Dhanaraj - Raritan NJ, US
International Classification:
A61K 35/12
A61P 9/00
B65D 71/00
A61P 17/02
C12P 21/00
A61K 35/44
A61P 9/10
US Classification:
424 937, 435 681, 206223
Abstract:
The invention relates to a fibrin-based scaffold suitable for supporting a population of cells comprising mesenchymal stem cells (MSC) and/or umbilical tissue derived cells (UTC) at the site of administration for a prolonged period of time. The scaffold is capable of supporting at least 1×10cells/ml scaffold. The invention also relates to the preparation of the scaffold and to its use. Preparation of the scaffold is carried out with a fibrinogen component comprising fibrinogen having a final concentration of higher than 17.5 mg/ml scaffold. The scaffold and the embedded MSC and/or UTC can be used for increasing vascularization and/or wound healing at the site of administration.
Control profile
Charito S Buensuceso from Hopkinton, MA, age ~56 Get Report